How big is the Gastric Cancer Therapy Market?

The Gastric Cancer Therapy Market size is expected to reach USD 5.32 billion in 2024 and grow at a CAGR of 12.63% to reach USD 9.64 billion by 2029. Read More

What is the current Gastric Cancer Therapy Market size?

In 2024, the Gastric Cancer Therapy Market size is expected to reach USD 5.32 billion. Read More

Who are the key players in Gastric Cancer Therapy Market?

Eli Lilly and Company, Pfizer Inc., F. Hoffmann-La Roche Ltd, Celltrion Inc. and Merck & Co are the major companies operating in the Gastric Cancer Therapy Market. Read More

Which is the fastest growing region in Gastric Cancer Therapy Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Gastric Cancer Therapy Market?

In 2024, the North America accounts for the largest market share in Gastric Cancer Therapy Market. Read More

What years does this Gastric Cancer Therapy Market cover, and what was the market size in 2023?

In 2023, the Gastric Cancer Therapy Market size was estimated at USD 4.72 billion. The report covers the Gastric Cancer Therapy Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Gastric Cancer Therapy Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Gastric Cancer Therapy Companies

This report lists the top Gastric Cancer Therapy companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Gastric Cancer Therapy industry.